CI insiders

26 insiders have filed at CI since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Cordani DavidChairman & CEO647.6k0.245%1 buys $1000k22 sells $56.0M
Palmer Eric PSee Remarks67.9k0.026%3 sells $4.3M
Evanko Brian CSee Remarks64.4k0.024%3 sells $4.0M
Triplett Michael WSpecial Advisor41.0k0.016%3 sells $2.9M
Foss Eric JDirector35.9k0.014%
Jones Nicole SSee Remarks34.1k0.013%6 sells $21.7M
Zarcone Donna FDirector26.7k0.01%
Wiseman Eric CDirector23.2k<0.01%
Delaney William J IIIDirector17.5k<0.01%1 sells $922k
Brailer David JEVP & Chief Health Officer17.5k<0.01%
Eder Noelle KSee Remarks13.6k<0.01%2 sells $6.9M
Sanford Paul AEVP Operations8.9k<0.01%1 sells $445k
Dennison Ann MEVP, CFO7.7k<0.01%
Ryan CynthiaEVP, Chro7.7k<0.01%1 sells $1.1M
Koka Durga PrasadEVP, Global CIO7.3k<0.01%
Granger ElderDirector6.1k<0.01%3 sells $1.3M
Mcclellan Mark B.Director6.1k<0.01%
Mazzarella Kathleen MDirector6.1k<0.01%
Neville EverettSee Remarks5.7k<0.01%3 sells $4.5M
Ross Kimberly A.Director4.5k<0.01%
Kurian GeorgeDirector3.8k<0.01%
Hathi NeeshaDirector3.4k<0.01%
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer2.6k<0.01%3 sells $7.2M
Kates Jamie GChief Accounting Officer2.4k<0.01%
Ozuah PhilipDirector1.8k<0.01%
Hennigan Michael JDirector568<0.01%

Full register at boothcheck.com/insiders/CI. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

CI institutional holders · CI research report